Alkermes Announces Positive Topline Results From Innovative Study of ARISTADA® and INVEGA SUSTENNA® for the Treatment of Schizophrenia - BioSpace

Submitted by Anonymous (not verified) on Tue, 04/09/2019 - 11:54

Alkermes Announces Positive Topline Results From Innovative Study of ARISTADA® and INVEGA SUSTENNA® for the Treatment of Schizophrenia  BioSpacePublished: Apr 09, 2019. Large, randomized ALPINE trial showed both long-acting injectable medications effectively controlled schizophrenia symptoms ...